Katie Mycock

Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer in Argentina: The IRIS Study

John Waller, Debanjali Mitra, Katie Mycock et al. · Journal of Global Oncology · 2019 · 53 citations · Full text

Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13‐country patient and caregiver survey

Heide Siggelkow, B.L. Clarke, John Germak et al. · Clinical Endocrinology · 2019 · 47 citations · Full text

Real-World Palbociclib Use in HR+/HER2− Advanced Breast Cancer in Canada: The IRIS Study

Katie Mycock, Lin Zhan, Gavin Taylor‐Stokes et al. · Current Oncology · 2021 · 31 citations · Full text

Real-World Treatment of Patients with Palbociclib for HR+/HER2-Advanced/Metastatic Breast Cancer: The Europe IRIS Study

Katie Mycock, Lin Zhan, Kieran Hart et al. · Future Oncology · 2021 · 22 citations · Full text

Real-world Treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy: A Multinational, Pooled Analysis From the Ibrance Real World Insights Study

Katie Mycock, Kent A. Hanson, Gavin Taylor‐Stokes et al. · Clinical Therapeutics · 2022 · 18 citations

Non-pharmacological Intervention, Clinical Outcomes Associated, Symptomatic Treatment +8